Pembrolizumab与多西紫杉醇在晚期经治PD-L1阳性非小细胞肺癌患者中的疗效比较

    Compare the Curative Effect of Pembrolizumab and Docetaxel for Previously Treated PD-L1-Positive Advanced Non-Small Cell Lung Cancer

    /

    返回文章
    返回